Seattle, WA, United States of America

Mark Litton

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 240(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Mark Litton: A Pioneer in Biotech Innovations

Introduction

Mark Litton, a renowned inventor based in Seattle, WA, has made significant contributions to the field of biotechnology, holding an impressive portfolio of 20 patents. His work focuses on innovative methods for synthesizing complex proteins and therapeutic solutions aimed at improving patient health.

Latest Patents

Among his most recent patents, Mark has developed methods for synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy. This groundbreaking technique allows for the synthesis and secretion of recombinant hetero-multimeric proteins in mating-competent yeast. By transforming expression vectors into haploid cells that synthesize non-identical polypeptides, he enables the creation of diploid strains capable of producing and secreting biologically functional proteins.

In addition, Mark holds a patent for antagonists of IL-6, intended to prevent or treat cachexia, weakness, fatigue, and fever. This invention utilizes antibodies with specificity for IL-6, designed to improve the quality of life for patients exhibiting elevated serum C-reactive protein levels.

Career Highlights

Mark Litton has worked with several esteemed organizations throughout his career. Notably, he has been involved with Alder Bio Holdings LLC and Keck Graduate Institute, contributing his expertise to advance biomedical research and application.

Collaborations

Throughout his journey, Mark has collaborated with notable coworkers John A. Latham and Randall Schatzman. These partnerships have fostered a productive environment for innovation and development, leading to the generation of impactful inventions in the biotech industry.

Conclusion

Mark Litton's impressive track record of patents and his dedication to advancing biotechnological innovations underscore his status as a leading inventor in his field. His work not only reflects excellence in scientific research but also holds the potential to greatly improve patient outcomes in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…